Manufacturer
ORION CORP
Contents
Salbutamol sulfate
Indication
Acute bronchospasm/Acute severe asthma/Prophylaxis of exercise-induced bronchospasm
Instruction
As metered-dose aerosol or dry powd inhaler (90 or 100 mcg/actuation): 1 or 2 inhalations up to 4 times daily. Max: 800 mcg daily.
Drug interaction
Increased risk of hypokalaemia w/ K depleting agents (e.g. corticosteroid, diuretics, xanthines, digoxin). Increased uterine inertia w/ halogenated anaesth (IV). Increased risk of pulmonary oedema w/ corticosteroids. May antagonise the effect of anti-diabetics. Effects may be altered by guanethidine, reserpine, methyldopa, TCAs and MAOIs. Increased risk of CV effects w/ other sympathomimetic agents. Antagonistic effect w/ β-blockers.
Malaysia
